Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in interest of Director - Ow Chio Kiat

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024834 <b>Size:</b> 869 KB

Financial Statements and Related Announcement: Full Yearly Results

(75% Positive) DYCOM INDUSTRIES INC (DY) Reports Q3 2026 Financial Results

Dycom Announces Authorization of a New $150 Million Stock Repurchase Program

New Form NPORT-P - SPROTT FOCUS TRUST INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001410368-26-085891 <b>Size:</b> 36 KB

New Form N-PX - PIMCO Global StocksPLUS & Income Fund <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001050269-26-000057 <b>Size:</b> 112 KB

New Form 424B2 - US BANCORP \DE\ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024833 <b>Size:</b> 236 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024832 <b>Size:</b> 816 KB

New Form N-PX - CINCINNATI FINANCIAL CORP <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001104659-26-101132 <b>Size:</b> 49 KB

Insmed to Present at September 2026 Investor Conferences

(99% Positive) J M SMUCKER CO (SJM) Reports Q3 2026 Financial Results

New Form N-PX - PCM FUND, INC. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001050269-26-000056 <b>Size:</b> 71 KB

Definium Therapeutics to Participate at Upcoming Investor Conferences and Events

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024831 <b>Size:</b> 989 KB